全球皮下避孕植入市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計皮下避孕植入市場規模將從 2025 年的 9.9 億美元成長到 2034 年的 20 億美元，2026 年至 2034 年的複合年成長率為 8.14%。

受尋求有效計劃生育方案的女性對長效可逆避孕（LARC）方法需求不斷成長的推動，皮下植入式避孕植入市場預計將迎來顯著成長。人們對生殖健康和避孕重要性的認知不斷提高，促使皮下植入的使用量激增。這些植入提供了一種便捷、隱藏的避孕方法，只需極少的維護即可有效避孕數年。植入設計和配方方面的創新提高了這些裝置的安全性和有效性，使其成為醫療保健提供者和患者更具吸引力的選擇。

此外，對女性健康和賦權的日益關注正在影響皮下植入避孕市場。隨著越來越多的女性尋求掌控自己的生育選擇，對便利有效的避孕方法的需求也不斷成長。醫療保健機構所進行的教育活動和宣傳項目，旨在向女性普及植入避孕的益處和可及性，這也促進了該市場的成長。

此外，對避孕技術研發的日益重視正在推動皮下植入式避孕器市場的創新。製藥公司、醫療機構和研究機構之間的合作正在推動植入技術的進步，從而開發出能夠解決當前限制並改善患者照護的新一代產品。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球皮下避孕植入市場（依產品分類）

• 市場分析、洞察與預測
• 依托孕烯植入
• levonorgestrel植入

5. 全球皮下避孕植入市場（依通路分類）

• 市場分析、洞察與預測
• 醫院
• 婦科診所
• 社區醫療中心
• 其他

6. 全球皮下避孕植入市場（按地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Merck & Co.Inc
  • Shanghai Dahua Pharmaceutical Co., Ltd
  • Bayer AG
  • Baxter
  • BD
  • Gerresheimer AG
  • PfizerInc
  • Novartis AG
  • SCHOTT
  • Eli Lilly And Company
  • Sandoz Group AG
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • West Pharmaceutical ServicesInc
  • SHL Medical AG
  • Insulet Corporation

The Subdermal Contraceptive Implants Market size is expected to reach USD 2.00 Billion in 2034 from USD 0.99 Billion (2025) growing at a CAGR of 8.14% during 2026-2034.

The subdermal contraceptive implants market is poised for significant growth, driven by the increasing demand for long-acting reversible contraceptive (LARC) methods among women seeking effective family planning solutions. As awareness of reproductive health and the importance of contraceptive options rises, the adoption of subdermal implants is surging. These implants offer a convenient and discreet method of contraception, providing protection against pregnancy for several years with minimal maintenance. Innovations in implant design and formulation are enhancing the safety and efficacy of these devices, making them more appealing to healthcare providers and patients alike.

Moreover, the growing emphasis on women's health and empowerment is influencing the subdermal contraceptive implants market. As more women seek control over their reproductive choices, the demand for accessible and effective contraceptive options is increasing. The integration of educational initiatives and outreach programs is also contributing to the growth of this market, as healthcare providers work to inform women about the benefits and availability of subdermal implants.

Furthermore, the increasing focus on research and development in contraceptive technologies is fostering innovation in the subdermal contraceptive implants market. Collaborations between pharmaceutical companies, healthcare providers, and research organizations are driving advancements in implant technology, leading to the development of next-generation products that address current limitations and improve patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Etonogestrel Implant
• Levonorgestrel Implant

By Distribution Channel

• Hospital
• Gynecology Clinics
• Community Health Care Centres
• Others

COMPANIES PROFILED

• Merck Co, Inc, Shanghai Dahua Pharmaceutical Co, Ltd, Bayer AG, Baxter, BD, Gerresheimer AG, Pfizer, Inc, Novartis AG, SCHOTT, Eli Lilly and Company, Sandoz Group AG, Terumo Corporation, Teva Pharmaceutical Industries Ltd, West Pharmaceutical Services, Inc, SHL Medical AG, Insulet Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Etonogestrel Implant Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Levonorgestrel Implant Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Gynecology Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Community Health Care Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Merck & Co.Inc
  • 8.2.2 Shanghai Dahua Pharmaceutical Co., Ltd
  • 8.2.3 Bayer AG
  • 8.2.4 Baxter
  • 8.2.5 BD
  • 8.2.6 Gerresheimer AG
  • 8.2.7 PfizerInc
  • 8.2.8 Novartis AG
  • 8.2.9 SCHOTT
  • 8.2.10 Eli Lilly And Company
  • 8.2.11 Sandoz Group AG
  • 8.2.12 Terumo Corporation
  • 8.2.13 Teva Pharmaceutical Industries Ltd
  • 8.2.14 West Pharmaceutical ServicesInc
  • 8.2.15 SHL Medical AG
  • 8.2.16 Insulet Corporation